VMP 35917411000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Tetracosactide 250micrograms/1ml solution for injection ampoules
BNF code 0605010T0AAAAAA
Virtual Therapeutic Moiety Tetracosactide
Date identifier became valid 19 Oct 2018
Previous product identifier 325828004
Abbreviated name Tetracosactide 250micrograms/1ml inj ampoules
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 28 Jun 2004
Previous name Tetracosactide 250micrograms/ml injection 1ml ampoules
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Non-availability Actual Products Available
Non-availability status date 28 Nov 2014
Dose form Discrete
Unit dose form size 1.000
Unit dose form units ml
Unit dose unit of measure ampoule
Virtual Product Ingredient
Ingredient Tetracosactide acetate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninjection.intramuscular
Ontology Drug Form & Route
Form & Route solutioninjection.intravenous
Dose Form
Formulation Solution for injection
Drug Route
Route Intramuscular
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd)
Tetracosactide 250micrograms/1ml solution for injection ampoules (CST Pharma Ltd)
Virtual Medicinal Product Packs
Tetracosactide 250micrograms/1ml solution for injection ampoules 1 ampoule
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback